[go: up one dir, main page]

NO850300L - PROCEDURE FOR PREPARING 3-IMIDAZOLYLMETHYL-TETRAHYDROCARBAZOLONE DERIVATIVES - Google Patents

PROCEDURE FOR PREPARING 3-IMIDAZOLYLMETHYL-TETRAHYDROCARBAZOLONE DERIVATIVES

Info

Publication number
NO850300L
NO850300L NO850300A NO850300A NO850300L NO 850300 L NO850300 L NO 850300L NO 850300 A NO850300 A NO 850300A NO 850300 A NO850300 A NO 850300A NO 850300 L NO850300 L NO 850300L
Authority
NO
Norway
Prior art keywords
imidazolylmethyl
preparing
procedure
tetrahydrocarbazolone
derivatives
Prior art date
Application number
NO850300A
Other languages
Norwegian (no)
Other versions
NO164025B (en
NO164025C (en
Inventor
Ian Harold Coates
James Angus Bell
David Cedric Humber
George Blanch Ewan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848401888A external-priority patent/GB8401888D0/en
Priority claimed from GB848425959A external-priority patent/GB8425959D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO850300L publication Critical patent/NO850300L/en
Publication of NO164025B publication Critical patent/NO164025B/en
Publication of NO164025C publication Critical patent/NO164025C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO850300A 1984-01-25 1985-01-25 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-IMIDAZOLYLMETHYL-TETRAHYDROCARBAZOLONE DERIVATIVES. NO164025C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848401888A GB8401888D0 (en) 1984-01-25 1984-01-25 Heterocyclic compounds
GB848425959A GB8425959D0 (en) 1984-10-15 1984-10-15 Heterocyclic compounds

Publications (3)

Publication Number Publication Date
NO850300L true NO850300L (en) 1985-07-26
NO164025B NO164025B (en) 1990-05-14
NO164025C NO164025C (en) 1990-08-22

Family

ID=26287221

Family Applications (2)

Application Number Title Priority Date Filing Date
NO850300A NO164025C (en) 1984-01-25 1985-01-25 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-IMIDAZOLYLMETHYL-TETRAHYDROCARBAZOLONE DERIVATIVES.
NO1994022C NO1994022I1 (en) 1984-01-25 1994-11-09 Ondansetron / 1,2,3,4-tetrahydro-9-methyl-3- (2-methylimidazol-1-ylmethyl) -carbazol-4-one

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1994022C NO1994022I1 (en) 1984-01-25 1994-11-09 Ondansetron / 1,2,3,4-tetrahydro-9-methyl-3- (2-methylimidazol-1-ylmethyl) -carbazol-4-one

Country Status (29)

Country Link
KR (1) KR920003064B1 (en)
AT (1) AT392276B (en)
AU (1) AU579132B2 (en)
BE (1) BE901576A (en)
CA (1) CA1252793A (en)
CH (1) CH664152A5 (en)
CY (1) CY1479A (en)
CZ (1) CZ404391A3 (en)
DE (2) DE3502508A1 (en)
DK (1) DK169521B1 (en)
ES (3) ES8609309A1 (en)
FI (1) FI84349C (en)
FR (1) FR2561244B1 (en)
GB (1) GB2153821B (en)
GR (1) GR850219B (en)
HK (1) HK33189A (en)
HU (1) HU193592B (en)
IE (1) IE57809B1 (en)
IL (1) IL74165A (en)
IT (1) IT1182150B (en)
LU (2) LU85743A1 (en)
NL (2) NL190373C (en)
NO (2) NO164025C (en)
NZ (1) NZ210940A (en)
PH (1) PH22672A (en)
PT (1) PT79890B (en)
SE (1) SE460359B (en)
SG (1) SG7089G (en)
SK (1) SK277923B6 (en)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
DE3689974T2 (en) * 1985-03-14 1994-11-03 Beecham Group Plc Medicines to treat emesis.
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
US5204356A (en) * 1985-07-24 1993-04-20 Glaxo Group Limited Treatment of anxiety
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (en) * 1986-07-30 1988-02-16 Sandoz Ag METHOD FOR THE THERAPEUTIC USE OF SEROTONIN ANTAGONISTS, ACTIVE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
AT396870B (en) * 1986-08-07 1993-12-27 Sandoz Ag Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
DE3777805D1 (en) * 1986-11-21 1992-04-30 Glaxo Group Ltd MEDICINES FOR TREATING OR PREVENTING THE WITHDRAWAL SYNDROME.
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
US5202343A (en) * 1986-11-28 1993-04-13 Glaxo Group Limited Tricyclic ketones useful as HT3 -receptor antagonists
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
DE3782028T2 (en) * 1986-12-17 1993-02-18 Glaxo Group Ltd USE OF KETONE DERIVATIVES FOR THE TREATMENT OF AWARENESS GIVING.
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
JPS63277622A (en) * 1986-12-17 1988-11-15 グラクソ、グループ、リミテッド Medicine
DE3876006T2 (en) * 1987-04-14 1993-03-25 Glaxo Group Ltd KETONE DERIVATIVES.
EP0295836B1 (en) * 1987-06-16 1992-09-02 Btg International Limited Use of dioxopiperidine derivatives for the manufacture of topical medicaments as analgesics
DE3822792C2 (en) * 1987-07-11 1997-11-27 Sandoz Ag New use of 5HT¶3¶ antagonists
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
EP0317088A1 (en) * 1987-10-22 1989-05-24 Glaxo Group Limited Ketone derivatives
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US5116984A (en) * 1988-04-07 1992-05-26 Glaxo Group Limited Imidazole derivatives
DK185489A (en) * 1988-04-22 1989-10-23 Duphar Int Res IMIDAZOLYLMETHYL-CYCLOALKANOEBAA INDOLONES, THEIR PREPARATION AND USE
JPH0256485A (en) * 1988-04-27 1990-02-26 Glaxo Group Ltd Lactam derivative
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
US5173493A (en) * 1988-09-27 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Pyridoindole derivatives and processes for preparation thereof
US5290785A (en) * 1988-09-27 1994-03-01 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for ischemic diseases
FR2639944B1 (en) * 1988-12-06 1991-01-18 Adir NEW INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
CA2012092A1 (en) * 1989-03-13 1990-09-13 Tadao Okegawa 5-ht3 receptor antagonist
CA2031214A1 (en) * 1989-04-21 1990-10-22 Alberto Azcona Therapeutic use of 5-ht receptor antagonists
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
GB8917557D0 (en) * 1989-08-01 1989-09-13 Glaxo Group Ltd Medicaments
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
WO1993000074A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
JPH05310732A (en) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp Cinnoline-3-carboxylic acid derivative
ES2043535B1 (en) * 1992-03-13 1994-08-01 Vita Invest Sa PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
US5607938A (en) * 1993-03-08 1997-03-04 Fujisawa Pharmaceutical Co., Ltd. Medicament for treating or preventing cerebrovascular infarction
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB2327348A (en) * 1994-06-28 1999-01-27 Kenneth Francis Prendergast Pharmaceutical use of ondansetron
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
RU2207340C2 (en) * 2001-08-10 2003-06-27 Ципла Лтд. Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazole-4-one or its pharmaceutically acceptable salts
EP1499623B1 (en) 2002-04-29 2007-06-13 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one
FI6164U1 (en) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronformer
GB2398071B (en) * 2003-01-24 2006-06-07 Synthon Bv Process for making ondansetron and intermediate thereof
ES2238001B1 (en) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. NEW POLYMORPHIC FORMS OF ONDANSETRON, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANANTIMETICS.
US7288660B2 (en) 2004-05-07 2007-10-30 Taro Pharmaceutical Industries Limited Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20090170872A1 (en) * 2005-07-05 2009-07-02 Orchid Research Laboratories Limited Compounds and Their Pharmaceutical Use
ES2432618T3 (en) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of a pathology of the inner ear with vestibular deficit
KR101779991B1 (en) 2009-05-20 2017-09-19 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
CN115611864A (en) * 2022-11-01 2023-01-17 常州兰陵制药有限公司 A kind of ondansetron compound and its preparation method and application
GB202301322D0 (en) 2023-01-30 2023-03-15 Therakind Ltd Antiemetic pharmaceutical compositions for nasal delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740404A (en) * 1969-05-09 1973-06-19 American Cyanamid Co Piperidinomethylenedihydrocarbazolones
US3634420A (en) * 1969-05-09 1972-01-11 American Cyanamid Co 3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives

Also Published As

Publication number Publication date
ES556101A0 (en) 1987-12-16
CH664152A5 (en) 1988-02-15
GB2153821A (en) 1985-08-29
IL74165A (en) 1988-11-15
GR850219B (en) 1985-05-23
IT8547600A0 (en) 1985-01-25
DK35785D0 (en) 1985-01-25
HK33189A (en) 1989-04-28
LU85743A1 (en) 1986-08-04
FI84349B (en) 1991-08-15
DE3502508C2 (en) 1990-05-03
ES548430A0 (en) 1987-10-01
NL8500202A (en) 1985-08-16
FI850323L (en) 1985-07-26
SK404391A3 (en) 1995-08-09
CA1252793A (en) 1989-04-18
HU193592B (en) 1987-11-30
ES8801247A1 (en) 1987-12-16
PT79890B (en) 1987-02-03
ES8708224A1 (en) 1987-10-01
SE8500368D0 (en) 1985-01-25
SK277923B6 (en) 1995-08-09
NL190373C (en) 1994-02-01
ES8609309A1 (en) 1986-07-16
PH22672A (en) 1988-11-14
SG7089G (en) 1989-06-09
PT79890A (en) 1985-02-01
KR850005439A (en) 1985-08-26
NO1994022I1 (en) 1994-11-09
NL940009I1 (en) 1994-07-18
IT1182150B (en) 1987-09-30
ATA20485A (en) 1990-08-15
NO164025B (en) 1990-05-14
AU3809785A (en) 1985-08-01
DE3502508A1 (en) 1985-08-14
IE57809B1 (en) 1993-04-21
HUT37784A (en) 1986-02-28
SE460359B (en) 1989-10-02
CY1479A (en) 1989-07-21
FR2561244A1 (en) 1985-09-20
NL940009I2 (en) 1999-05-03
NO164025C (en) 1990-08-22
NL190373B (en) 1993-09-01
GB2153821B (en) 1988-01-20
FR2561244B1 (en) 1988-03-04
DE19375046I2 (en) 2002-10-10
IE850187L (en) 1985-07-25
FI84349C (en) 1991-11-25
FI850323A0 (en) 1985-01-25
SE8500368L (en) 1985-07-26
BE901576A (en) 1985-07-25
GB8501889D0 (en) 1985-02-27
CZ404391A3 (en) 1993-04-14
ES539852A0 (en) 1986-07-16
LU88268I2 (en) 1994-02-03
AU579132B2 (en) 1988-11-17
DK35785A (en) 1985-07-26
AT392276B (en) 1991-02-25
DK169521B1 (en) 1994-11-21
KR920003064B1 (en) 1992-04-13
NZ210940A (en) 1989-08-29

Similar Documents

Publication Publication Date Title
NO850300L (en) PROCEDURE FOR PREPARING 3-IMIDAZOLYLMETHYL-TETRAHYDROCARBAZOLONE DERIVATIVES
NO164242C (en) PROCEDURE FOR PREPARING PYRIDO-IMIDAZO-RIFAMYCIN DERIVATIVES.
ES540441A0 (en) PROCEDURE FOR PREPARING ACID DERIVATIVES NAFTIRIDIN- QUINOLIN- AND BENZOXAZIN-CARBOXYLICS
NO874764L (en) PROCEDURE FOR THE PREPARATION OF 2-AMINOPURIN DERIVATIVES.
ES540464A0 (en) PROCEDURE FOR PREPARING PLEUROMUTILINE DERIVATIVES
NO851466L (en) PROCEDURE FOR PREPARING 9A-AZA-9A-HOMOERY-TROMYCIN DERIVATIVES.
NO863608D0 (en) PROCEDURE FOR PREPARING BENZIMIDAZOLD DERIVATIVES.
ES544400A0 (en) PROCEDURE FOR PREPARING AMIN DERIVATIVES
NO862860D0 (en) PROCEDURE FOR PREPARING POLY-4-AMINOPYRROLE-2-CARBOXAMIDODE DERIVATIVES.
ES539717A0 (en) PROCEDURE FOR PREPARING AZOLYLALKYL DERIVATIVES
NO820980L (en) PROCEDURE FOR PREPARING IMIDAZO-PYRIMIDINE DERIVATIVES
NO164030C (en) PROCEDURE FOR THE PREPARATION OF IMIDAZO-RIFAMYCIN DERIVATIVES.
NO851550L (en) PROCEDURE FOR PREPARING IMIDAZOLD DERIVATIVES
ES551481A0 (en) PROCEDURE FOR PREPARING IMINOTIAZOLIDINIC DERIVATIVES
NO165107C (en) PROCEDURE FOR PREPARING PYRIDO-IMIDAZO-RIFAMYCIN DERIVATIVES.
NO841965L (en) PROCEDURE FOR PREPARING 1,8-DIHYDROXY-10-ACYL-9-ANTRON DERIVATIVES
ES543985A0 (en) PROCEDURE FOR PREPARING BUTIRAMIDE DERIVATIVES
NO845016L (en) PROCEDURE FOR PREPARING SUBSTITUTED SPIROPYRIDINE DERIVATIVES
NO851130L (en) PROCEDURE FOR CELLULOSE PREPARATION
ES547090A0 (en) PROCEDURE FOR PREPARING BENZAZOL DERIVATIVES
NO844466L (en) PROCEDURE FOR PREPARING PYRIMIDOISOKINOLINE DERIVATIVES
NO841485L (en) PROCEDURE FOR PREPARING SUBSTITUTED DIPENYLAZOMETIN DERIVATIVES
ES546140A0 (en) PROCEDURE FOR PREPARING AMINOLACTONES
ES541140A0 (en) PROCEDURE FOR PREPARING CARBOXIAL-KILDIPEPTIDE DERIVATIVES
NO823939L (en) PROCEDURE FOR PREPARING BENZOPYRANON DERIVATIVES

Legal Events

Date Code Title Description
MK1K Patent expired